In this episode, learn about specialty pharmacies, the specialty drug pipeline, and how Evernorth’s specialty pharmacy capabilities help patients and their plan sponsors get the most out of these innovative medicines in the most cost-effective way.

David Cordani, chairman and CEO of The Cigna Group, joined CNBC’s Mad Money for an interview with host Jim Cramer, where the two discussed the promise of biosimilars as well as our organization's strategy for pharmacy benefits management.

The healthcare outlook for 2023 and beyond has a number of encouraging trends for employers who provide health insurance to employees and their families. Read on to learn about four top healthcare topics and how they will impact American businesses.

If you don’t have health insurance through your job, choosing a health plan can feel overwhelming – but with the right information, finding affordable, quality healthcare can be simple.

As promising biosimilar therapies to treat inflammatory conditions become available next year, Cigna Pharmacy, which manages pharmacy benefits for some Cigna clients, is announcing that it will add biosimilars as preferred products on its commercial formularies at the same position as Humira.

Cigna has found that the average annual price of therapy for specialty drugs is $38,000 per patient, which is 75 times higher than non-specialty prescription drugs.

Two years ago, Cigna Corporation created Evernorth – an organization dedicated to making health care better. Today, we’re celebrating our successes and looking forward to the future.

Cigna’s leaders gathered recently in New York City for our first in-person Investor Day since the pandemic began. Chairman and Chief Executive Officer David Cordani and other company leaders spoke with the investment community and shareholders, illustrating the many ways we are delivering on our mission and investing in a rapidly changing future.

Cigna Chairman and CEO David Cordani sat down with Arianna Huffington, CEO of Thrive Global, to talk about worsening mental health among teens, the promise of pharmacological innovation, virtual care and the profound power of micro-communities.

Cigna Corporation Chairman and CEO David Cordani spoke with J.P. Morgan's Lisa Gill about the opportunities ahead in pharmaceutical innovation and personalized health care services.